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ABSTRACT: The ruthenaphosphaalkenyls [Ru{P=CH(SiMe2R)}Cl(CO)(PPh3)2] (R = Me, Ph, Tol) have been prepared in good 
yield by the facile hydroruthenation of the respective phosphaalkynes, RMe2SiC≡P, with [RuHCl(CO)(PPh3)3]; all three compounds 
have been structurally characterized in the solid state.  Complemented by DFT studies of these, and the precedent 
[Ru{P=CH(tBu)}Cl(CO)(PPh3)2], the phosphaalkenyl moieties have been established unequivocally to behave as one-electron do-
nors to the coordinately unsaturated, 15-electron ‘RuCl(CO)(PPh3)2’ fragment, corroborating earlier demonstration of nucleophilic 
character at phosphorus within the tert-butyl system.  Notwithstanding, the ruthenaphosphaalkenyls are shown to react with the 
nucelophiles Lipz’ (pz’ = pz, pz*, pzH,CF3, pzMe,CF3) to afford the η1,η2-chelated pyrazolylphosphaalkene complexes 
[Ru{η1−N:η2−P,C-P(pz’)=CH(R)}(CO)(PPh3)2], which feature a 3-membered metallacyclic (Ru−C−P) core.  The nature of these 
novel compounds is discussed, alongside preliminary insight into the process by which they are formed.      
INTRODUCTION 
The chemistry of low-coordinate phosphacarbons has been 
an active area of research for over four decades,1 and contin-
ues to be a topic of wide-spread interest.2  Amidst this con-
stantly developing field, phosphaalkenes (RP=CR’R’’) have 
long held particular importance, being among the earliest 
phosphacarbons to be studied in detail.3  In an organometallic 
context, while both the η1 and η2-coordination complexes of 
phosphaalkenes have been studied,4 albeit less extensively so 
for the latter case, a more prevalent interest has surrounded the 
metallaphosphaalkenes (A – E, Chart 1) in which at least one 
substituent on the ‘P=C’ moiety is replaced by either a transi-
tion metal fragment or main group metal.5   
Chart 1: Metallaphosphaalkenyl motifs 
 
With the exception of those of type E, all possible metalla-
phosphaalkene motifs have been realized, albeit that work has 
been overwhelmingly focused on the P-metalla- (type A) and 
C-metalla- (type B) systems.  These constitute intriguing ex-
tensions of the phosphacarbon paradigm “the carbon copy” in 
an organometallic context, particularly in respect of P-
metallaphosphaalkenyls (type A).  The first such compound, 
[CpFe(CO)2P=C(SiMe3)tBu], described in 1985,6 was obtained 
through an extension of Becker’s methodology, via the inter-
action of tBuC(O)Cl with the bis(trimethylsilyl)phosphide 
complex [CpFe(CO)2P(SiMe3)2].7  Subsequently, a range of 
such compounds was similarly obtained (Chart 2).8  Other 
prevalent synthetic routes have included: (i) metathesis of P-
halogenophosphaalkenes with carbonylmetallates;9 (ii) me-
tathesis of P–silylphosphaalkenes with transition metal halides 
(LnMX)10 and (iii) oxidative addition of P-functionalized 
(Cp*, Cl) phosphaalkenes to low-valent metal fragments 
(M(NCMe)3(CO)3 M = Cr, Mo, W; “Fe(CO)5”; Ni(PR3)2(cod); 
Pt(PPh3)2(C2H4)).11  The reduction of phosphaalkynes within 
the coordination sphere of a transition metal has also found 
some utility to this end, albeit typically accompanied by oli-
gomerization of phosphaalkyne units.12  Notably, however, in 
1996 Hill and Jones described the facile, stoichiometric, re-
duction of tBuC≡P by the ruthenium hydride complex 
[RuHCl(CO)(PPh3)3].13  Akin to the established alkyne hydro-
ruthenation protocols,14 this afforded the ruthenaphos-
phaalkenyl [Ru(P=CHtBu)Cl(CO)(PPh3)2] (1),13,15 the thiocar-
bonyl analogue of which was similarly obtained, alongside 
analogues derived from AdC≡P.15  Jones subsequently report-
ed the successful double hydroruthenation of his bicyclo-
[2.2.2]-octane-1,4-diphosphaalkyne,16 though Hill’s attempts 
to prepare an osmium analogue of 1 were thwarted by its fac-
ile incorporation of a second equivalent of  tBuC≡P to afford a 
phosphaalkenyl-phosphaalkene complex.17  
Chart 2: Representative P-Metallaphosphaalkenyls 
 
 Compound 1 is notable in featuring both a relatively unen-
cumbered phosphaalkenyl moiety (cf. the classical use of ste-
rically demanding and/or pi-dative substituents to confer stabil-
ity) and apparent unsaturation at the metal center.  For early 
transition metals, such unsaturation results in additional dona-
tion of the phosphaalkenyl lone pair to the metal, viz. adoption 
of a three-electron phosphavinylidene ligation mode,9a,c,18 re-
sulting in electrophilicity of the phosphorus center.  However, 
while structural data for 1 have not been described, the 
demonstration of nucleophilicity at phosphorus,19 in a series of 
1,2 additions across the P−Ru linkage, was deemed character-
istic of a ‘bent’ one-electron P-phosphavinyl ligand15 within 
an overall 16-electron complex; the latter was somewhat sup-
ported by isolation of 18-electron complexes upon addition of 
a series of 2-electron donors (CO, CNR), though a significant 
trans influence was noted for the phosphaalkenyl.13,15      
Notwithstanding, while investigating an analogue of 1, viz. 
[Ru{P=CH(SiMe3)}Cl(CO)(PPh3)2] (2), we have noted unex-
pected ambiphilic behavior.  Thus, as we have recently com-
municated,20 while 2 readily undergoes 1,2 additions con-
sistent with a nucleophilic phosphorus center, its interaction 
with the pyrazolates [pz’]− (pz’ = pz, pz*) also results in func-
tionalization at phosphorus.  Herein, we describe further inves-
tigation of this unusual behavior, including a structural study 
of the parent phosphaalkenyls. 
 
RESULTS AND DISCUSSION 
Ruthenaphosphaalkenyl complexes.  In a similar manner 
to that previously described for 1,13 the novel ruthenaphos-
phaalkenyls [Ru{P=CH(SiMe2R)}Cl(CO)(PPh3)2] (R = Me 2, 
Ph 3, p-Tol 4) were obtained from the reaction of 
[RuHCl(CO)(PPh3)3] with excess of the respective phos-
phaalkyne RMe2SiC≡P21,22 (Scheme 1), the latter generated as 
toluene solutions by the double dehydrochlorination of 
RMe2SiCH2PCl2.23     
Scheme 1: Synthesis of phosphaalkenyls 2- 4.a 
 
aReagents and conditions: i) 2 AgOTf, 2 DABCO, toluene; ii) 
[RuHCl(CO)(PPh3)3], CH2Cl2 
The identities of 2 − 4 follow convincingly from analytical 
and spectroscopic data.  Thus, the 31P-NMR spectra exhibit 
doublet-based resonances associated with the retained PPh3 
ligands (δP 34.6, 2; 33.7 3, 33.7 4), with mutual coupling (8 
Hz) to heavily deshielded resonances (δP 548.5, JPH = 21 Hz, 
2; 553.8, JPH = 20 Hz, 3, 552.6, JPH = 20 Hz 4) that lie in a 
region characteristic of P-metallaphosphaalkenyls.8-12  The 
latter collapse to triplets in the 31P{1H}-NMR spectra, con-
sistent with loss of the scalar interaction to their respective 
vinylic proton, the resonances for which are assigned on the 
basis of 31P-1H HMBC spectra (δH 7.28, 2; 7.40 3, 7.41 4), 
alongside their correlation to the carbon (δC 168.0 2; 163.7 3, 
165.2 4) and silicon (δSi −9.4 2, −14.3 3, −14.4 4) centers of 
the phosphaalkenyl moiety.  Retention of the carbonyl ligand 
is in each case confirmed by infrared data (νCO 1920 cm-1 2; 
1938 cm-1 3, 1936 4), the associated 13C{1H}-NMR resonances 
of which (δC 203.0 2; 201.9 3, 202.54) are also observed. 
It is noteworthy that the low-coordinate phosphorus centers 
of 2 − 4 are significantly more deshielded than that of 1 (δP 
450.413).  We attribute this to the differing substituent at the 
adjacent alkenic carbon (SiR3 vs tBu), given the similar dispar-
ity noted between the parent phosphaalkynes RC≡P (δP: R = 
Ph −67; SiMe3 98.7; SiMe2Ph 102.7, SiMe2Tol 103.3).  How-
ever, one cannot immediately discount the possibility of dif-
fering coordination modes; indeed, though compound 1 was 
concluded to involve a 1-electron phosphaalkenyl ligand (vide 
supra),15 the lack of structural verification, alongside a noted 
strong trans influence, do not fully preclude the possibility of 
some phosphavinylidene character (vide infra).     
From a structural stand-point, the silyl derivatives 2−4 (Fig-
ures 1 – 3, Table 1) would seem consistent with the phos-
phaalkenyl being engaged in 1-electron ligation to the metal.  
Thus, a distinctly ‘bent’ geometry is noted for the phos-
phaalkenyl moiety (∠ Ru−P−C 121.3(2) – 124.4(4) °; ∠ 
P−C−Si 122.5(7) – 125.6(2) °) with no evidence for lineariza-
tion.  The Ru−P linkages are relatively short (dRuP 2.226(2) – 
2.2503(10) Å) in comparison to ruthenium-phosphido com-
plexes (2.382 – 2.512 Å24), those of the η1-phosphaalkene 
complexes [Ru{η1-P(E)=CH(R)}Cl2(CO)(PPh3)2] (R = tBu, E 
= Au(PPh3),19b HgFc;19e R = SiMe3, E = HgPh;20 d(Ru-P) = 
2.256(2) – 2.296(2) Å) and that reported for Hill’s 18-electron 
phosphaalkenyl [Ru{P=CHtBu}(O2CH)(CO)(PPh3)2] (2.295(2) 
Å).15  They are also shorter than those reported by Peters for 
[Ru{κ4-Si(C6H4PPh2)3}{PR2)] (R = Ph 2.2700(3), iPr 
2.2592(4) Å), which exhibit appreciable Ru=P double bond 
character, as evidenced by planarity of the Ru-PR2 unit.25  
However, the distances of 2 − 4 do compare well with the 
Ru←PR3 distances recorded for other square-based pyramidal 
ruthenium(II) complexes (2.16 – 2.47 Å24), while the P=C 
bonds (dP=C 1.655(2) – 1.660(11) Å) are comparable to those 
of the η1-phosphaalkene complexes (1.662(5) – 1.69(2) Å),  
Hill’s 18-electron system (1.640(8) Å) and phosphaalkenyls 
more generally (1.65 – 1.75 Å).24 It is thus fair to conclude a 
lack of any higher-order character for the Ru−P linkage; this is 
also borne out by DFT studies (vide infra).   
 
Figure 1: Molecular structure of 2 in molecules of the Et2O solv-
ate; 50 % thermal ellipsoids, hydrogen atoms omitted for clarity.     
  
Figure 2: Molecular structure of 3; 50 % thermal ellipsoids, hy-
drogen atoms omitted for clarity.  
Table 1: Selected geometric data for compounds 2 – 4.a  
 
2b 3 4 
Ru−Palkenyl 2.226(2) 2.2468(5) 2.2504(8) 
Ru−CCO 1.735(9) 1.835(2) 1.824(3) 
P=C 1.660(11) 1.665(2) 1.655(3) 
C≡O 1.183(12) 1.143(3 1.163(4) 
    
Ru−P=C 124.4(4) 121.49(7) 121.31(11) 
P=C−Si 122.5(7) 124.88(12) 125.64(17) 
PPR3−Ru−PPR3 167.18(7) 166.615(6) 166.84(3) 
Cl−Ru−CCO 159.0(3) 162.68(6) 163.57(10) 
aBond distances (Å) and angles (°) with Estimated Standard 
Uncertainties (esds) in parentheses. bThe structure for 2 suffers 
from some disorder around the carbonyl carbon; associated pa-
rameters should be interpreted with caution.     
The molecular geometries are otherwise largely unremarka-
ble.  The interligand angles about ruthenium (∠ Cl−Ru−CO 
162.68(8) − 163.56(12) °; ∠ PPR3−Ru−PPR3 166.62(2) – 
167.18(7) °) are typical of square-based pyramidal Ru(II), and 
C≡O distances are similarly consistent.  The phosphaalkenyl 
moieties are in each case essentially coplanar with the carbon-
yl ligand (φ = 8.2(6) ° 2, 17.93(10) ° 3, 17.89(17) ° 4), with 
which they also adopt a cis conformation, as was observed for 
[Ru{P=CHtBu}(O2CH)(CO)(PPh3)2]15 and has been previously 
noted for analogous ruthenium vinyl complexes.24,26 In the 
latter cases, this has been attributed to achieving optimal dpi → 
pi* retrodonation to both the carbonyl and alkenyl ligands, 
coupled with a consequentially significant barrier to rotation 
about the Ru−Calkene linkage, and a marginal thermodynamic 
preference for the cis rather than trans arrangement (ca 2 kcal 
mol-1) of the two ligands.27  A comparable situation would 
seem likely for the phosphaalkenyl analogues.      
DFT studies.  The ground-state geometries of complexes 1 
− 4 were optimized using DFT methods, commencing either 
from the solid-state data (2 − 4) or from hypothetical models 
(1 and 2); in each case comparable geometries were obtained 
that compare well with the experimental (solid-state) struc-
tures of 2 − 4 (see supporting information). 
 
 
Figure 3: Molecular structure of 4; 50 % thermal ellipsoids, hy-
drogen atoms omitted for clarity. 
The calculated IR data (νCO) and 31P-NMR isotropic shield-
ing tensors (lanl2dz on Ru; 6-31G** all other atoms) of 1 − 4, 
show moderate agreement with experimental data, but do 
closely reflect the observed trends (Table 2).  In particular, the 
computed 31P-NMR shifts for the Palkenyl centers indicate ap-
preciably greater shielding within 1 (∆δP ~ −100 ppm w.r.t. 2) 
compared with the silyl systems; this substantiates the notion 
that this feature is of purely electronic origin (i.e. tBu vs 
SiMe2R) rather than being the result of any geometric distinc-
tiveness.  Indeed, attempts to optimize the geometry of 1 using 
a phosphavinylidene model resulted in relaxation to the phos-
phaalkenyl motif (Figure 4), which exhibits no evidence for 
involvement of the lone pair in metal binding. 
Table 2: Comparative calculated and experimental IR and 
NMR data.   
 νCO / cm-1 δP (Palkene) 
 Calc.a,b,c Exp.d B3LYPb,e PBEPBEb,e Exp.f 
1 1933.4 1929 482.0 455.4 450.4 
2 1938.5 1920 584.4 537.2 548.5 
3 1952.2 1938 606.8 558.0 553.8 
4 1951.8 1936 604.7 557.9 552.6 
aB3LYP. blanl2dz on Ru, 6-31G** on all other atoms. cfrequen-
cy scaling factor of 0.961 applied. dCH2Cl2 solutions.  eUsing 
GIAO method, referenced against H3PO4 at the same level of 
theory. fas CD2Cl2 solutions.   
For all four complexes the frontier orbitals are dominated by 
the metal and phosphaalkenyl fragments.  Thus, for 2 − 4 the 
HOMO involves appreciable bonding overlap between ruthe-
nium and the phosphaalkenyl σ-framework, and also incorpo-
rates the phosphorus lone-pair.  A somewhat lesser component 
of dpi→pi*(CO) retrodonation is also apparent.  The HOMO-1, 
which lies essentially orthogonal to the HOMO (with respect 
to the metal d orbitals and alkenyl moiety) and around 0.1 eV 
lower in energy, is composed of out-of-phase mixing of the 
metal dpi orbital and phosphaalkenyl pi-system, and in the cases 
of 3 and 4 a small contribution from the arene pi-orbitals.  For 
1, the HOMO and HOMO-1 are reversed, though again close 
in energy (0.09 eV) and with the same general composition.  
 
  
Figure 4: Optimized core geometry of 1, with phenyl rings and 
ancillary hydrogen atoms omitted for clarity.  Selected bond dis-
tance (Å) and angles (°): Ru−P 2.318, P=C 1.680, Ru−CO 1.846, 
C≡O 1.166, Cl−Ru−C 159.02, Ru−P−C 118.05 P=C−C 126.54. 
In all cases the LUMO is appreciably separated from the 
HOMO (3.76 – 3.87 eV), largely metal-based, and accessible 
to nucleophiles through the basal plane.  Interestingly, for 2 − 
4 the LUMO+1, which is only modestly higher in energy (ca 
0.6 eV), involves an appreciable contribution from the phos-
phaalkenyl pi* orbital; the equivalent orbital of 1 is at 
LUMO+2, ca 0.8 eV above the LUMO.  This is significant, 
given that NBO calculations indicate an appreciable δ+ char-
acter at the alkenyl phosphorus atom (0.55 – 0.76).  Taken 
together, these features would seem to imply the possibility of 
at least some electrophilic character for this center, alongside 
the unequivocally established nucleophilicity associated with 
the accessible lone pair (HOMO).  This has potential implica-
tions in respect of the noted ambiphilicity of these systems 
(vide infra).20 
 
Figure 5: Representative Frontier Orbitals for compound 2.  
Synthesis of η2-phosphaalkene complexes.  The ruthena-
phosphaalkenyls 1 − 3 all react readily, in thf solution, with 
single equivalences of the lithium pyrazolates Lipz’ (pz’ = pz, 
pz*) to afford in each case high yield of a single species (5 – 
10, Scheme 2).  As we have previously communicated,20 the 
connectivity of compounds 7 and 8 was established from X-
ray diffraction data, which were readily reconciled with char-
acteristic features of the multinuclear NMR spectra.  Thus, 
while 5, 6, 9 and 10 have yet to yield X-ray quality crystals, 
their comparable nature is apparent from their spectroscopic 
signatures (Table 3).  In all cases three (1:1:1) mutually cou-
pling resonances are apparent in the 31P{1H}-NMR spectra, in 
a region (10 – 60 ppm) typically characteristic of saturated 
phosphorus centers, while the heavily deshielded phos-
phaalkenyl resonance has been lost.  Notwithstanding, reten-
tion of the tBu (5, 6) or SiMe2R (7 – 10) moieties is apparent 
from the 1H NMR spectra (supported by 1H-29Si correlation for 
7 − 10), the respective resonances integrating consistently 
against those in the aromatic region, which indicate retention 
of both PPh3 ligands.  Moreover, 1H and 13C NMR resonances 
associated with the P−CH unit are observed, identified on the 
basis of correlation experiments, albeit in significantly more 
shielded positions; the ‘P−CHR’ unit can thus be concluded to 
be in-tact, albeit no longer phosphalkenyl in nature.  Finally, 
retention of the carbonyl ligand is confirmed by both charac-
teristic infrared and 13C{1H} NMR data.   
Scheme 2: Reactions of 1 − 3 with Lipz’ (pz’ = pz, pz*).a    
 
aReagents and conditions: i) Lipz’ (pz’ = pz, pz*), thf, r.t., 1 h. 
Comparable methodology is used to obtain 11 to 14 from LipzCF3 
and LipzMe,CF3 
The precise nature of the three-membered (Ru−C−P) cyclic 
core of these compounds is a matter of intrigue.  The crystal-
lographic data20 for 7 and 8 indicated significant pyramidaliza-
tion about the Calkene center (∠ P−C−H 112.8 °, ∠Si-C-H 112.8 
º, ∠ P-C-Si 116.7 º) with concomitant lengthening of the P−C 
linkage (1.793(6) Å), superficially consistent with a ruthena-
phosphirane geometry.  Indeed, 1H and 13C NMR spectroscop-
ic data would also seem to support such formalism, the 
‘P−CH’ moiety exhibiting shifts consistent with a saturated 
system (7: δH 1.59, δC 47.5; 8: δH 1.62, δC 44.9).  The C−H 
coupling magnitudes for the ‘P−CH’ moiety (JCH 137 Hz 7, 
123 Hz 8) are, however, more ambiguous, being intermediate 
between those characteristic of ‘sp3’ (cf. 125 Hz in CH4) and 
‘sp2’ (cf. 156 Hz in C2H4)28 models; moreover, minimal per-
turbation of the P−C coupling magnitude (1JPC ~79 Hz; cf. 1JPC 
= 77 Hz in 3) is also superficially consistent with retention of 
appreciable ‘sp2’ character.  Intermediate character is also 
reflected in the fact the P−C linkage remains shorter than both 
a typical P(sp3)−C(sp3) single bond (1.855(19) Å)29 and those 
of other known phosphiranes (1.8 – 1.9 Å24). 
The spectroscopic data for all compounds 5 − 10 show a 
consistent trend, though it is again noted that replacement of 
silyl with tert-butyl results in significant deshielding of the 
‘P−CH’ unit (cf. 1 vs 2 − 4).  This is markedly more pro-
nounced than for the parent phosphaalkenyls, which may sug-
gest a more ‘alkene-like’ character than for the silyl deriva-
tives; however, the magnitude of 1JCH in 6 (137 Hz) is compa-
rable, while a slightly greater variation in 1JPC coupling (67 Hz 
5, 69 Hz 6) over the alkenyl (1JPC ~ 59 Hz 113) may reflect a 
marginal increase in s-character.  Finally, infrared spectro-
scopic data for 5 − 10 indicate a significant reduction in the 
 Table 3: Spectroscopic data for η2-phosphaalkene complexes 5 – 14.a  
    δPb δCc δHc   
 R R’ R’’ P=C PPh3 P=C P=CH (1JCH / Hz)d νCOe / cm-1 kCO / N cm-1 
5 tBu H H 38.8 44.2, 42.5 81.6 2.84  1906 14.68 
6 tBu Me Me 14.7 45.5, 41.4 79.8 2.90 (137) 1902 14.62 
7 SiMe3 H H 58.7 46.6, 42.0 47.6 1.59 (137) 1907 14.69 
8 SiMe3 Me Me 32.9 46.6, 39.2 44.9 1.62 (123) 1906 14.68 
9 SiMe2Ph H H 57.0 47.0, 41.7 45.1 1.72 (135) 1913 14.79 
10 SiMe2Ph Me Me 32.3 47.0, 38.9 41.8 1.77 (128) 1910 14.74 
11 SiMe3 H CF3 76.6 47.7, 41.5 47.1 1.78 (136) 1912 14.77 
12 SiMe3 Me CF3 64.6 46.9, 38.4 45.2 1.76 (129) 1909 14.72 
13 SiMe2Ph H CF3 74.9 48.0, 41.3 46.7 1.91 (136) 1915 14.82 
14 SiMe2Ph Me CF3 62.7 47.2, 38.3 41.8 1.97 (131) 1909 14.72 
 
aNMR spectra recorded in CD2Cl2 for compounds 5 – 10 inclusive; CDCl3 11 − 14.   b referenced to 85 % H3PO4. c referenced to SiMe4. 
d
 measured using coupled 1H-13C- HSQC spectra.  e recorded as solutions in CH2Cl2. 
carbonyl stretching frequencies in comparison to the parent  
phosphaalkenyls.  Indeed, while νCO for the latter are entirely 
consistent with Ru(II) (vide supra; 1929 cm-1 for 1), those of 5 
−10 are more akin to the limited range of Ru(0) monocarbon-
yls reported to date (1910 – 1880 cm−1),30 while the force con-
stants for the C≡O bond are consistent with those derived from 
Ru(0) dicarbonyls.31 
Taken together, these data suggest that compounds 5 – 10 
are perhaps best described using the Dewar-Chatt-Duncanson 
model, and formulated as η2-phosphaalkene complexes.  Thus, 
dpi → pi*(P=C) retrodonation can be considered a dominant con-
tribution to metal-ligand binding (albeit potentially diminished 
in complexes 5 and 6, a corollary of reduced acceptor charac-
ter of tert-butyl compared with silyl), as was described by 
Cowley for [Ni{η2-(Me3Si)2C=PCH(SiMe3)2}(PMe3)] (dP=C 
1.773(8) Å),32 which also exhibited a significantly low-
frequency resonance for Palkene (δP 23).  More recently, Ionkin 
described a similar situation (δP 54) for his chelated phos-
phaalkene complex (Chart 3),33  the significant shift from the 
free ligand (δP 248), which was mirrored in the 13C data (δC 
67, cf. 181 for the free ligand), being deemed consistent with 
an η2-coordination mode.  These data fit well with the trends 
noted herein. 
A further notable feature in the spectroscopic data of 5  − 10 
is the appreciable shielding of the Palkene center in the 1,3-
dimethylpyrazole derivatives, compared with their pyrazole 
analogues, presumably reflecting the enhanced donor strength 
of pz* over pz.  This was verified by preparing the analogues 
11 − 14, which incorporate pzCF3
 
and pzMe,CF3 moieties.34  The 
spectroscopic data (Table 3) in each case reflect the anticipat-
ed trend in δP for the Palkene center (pz* < pz < pzMe,CF3 < pzCF3), 
the more electron-withdrawing CF3 moiety imparting appre-
ciable deshielding.  It is noteworthy that in each of 11 − 14 a 
single positional isomer is apparently formed in respect of the 
pyrazolyl substituents, the assignment of which is non-trivial 
in lieu of structural data.  However, while the CF3 moieties 
exhibit correlation to both Palkene and one of the PPh3 ligands, 
only for the former is an appreciable coupling observed (4JPF ~ 
20 Hz), consistent with CF3 being proximal to the Palkene cen-
ter.  This can be rationalized in terms of the steric demand of 
accommodating the bulkier CF3 (cf. Me) between flanking 
PPh3 units.  Indeed, reacting 2 or 3 with Lipz(CF3)2, for which 
this is unavoidable, fails to afford the fluorinated analogues of 
8 and 10, resulting instead in degradation of the ruthenaphos-
phaalkenyls; comparable results are noted with Lipz(tBu)2, thus 
negating the possibility of an electronic effect associated with 
the bis-trifluoromethyl system.   
Chart 3: A chelated ruthenium η2-phosphaalkene complex. 
 
DFT studies.  The optimized ground-state geometries of 5 
and 7 (Figure 6) both show good agreement with the solid 
state data for the latter.20  There is only marginal variation in 
geometry about the P−CH moiety, 5 exhibiting a slightly wid-
er P−C−R angle (119.24 °, cf. 117.23 ° in 7) and increased 
displacement of carbon from the metal center (2.244 Å, cf. 
2.240 Å in 7), while other parameters are comparable. This 
would seem to exclude significant variation in the extent of 
‘alkene’ character being responsible for the observed spectro-
scopic variations between silyl and tBu systems.  Indeed, 
though the calculated isotropic shielding tensors for 5 and 7 
(31P, 13C and 1H) are in less close agreement than for their par-
ent phopshaalkenyls (vide supra), they do mirror the experi-
mental trend.  Thus, for the ‘P−CH’ fragment, the phosphorus 
center of 5 resonates at somewhat lower frequency than that of 
7 (∆δP = −13.6 cf. −19.9 expt.), while significant deshielding is 
also apparent for both 13C and 1H nuclei (∆δC = 31.4, ∆δH = 
1.25; cf. 34.0 and 1.22 expt.).  The calculated carbonyl stretch-
ing frequencies correlate well with the experimental data, the 
significant decrease from those of the parent phosphaalkenyls 
being consistent with reduction of the metal (Ru(II) → Ru(0)), 
as previously inferred (vide supra).   
  
Figure 6: Optimized geometries of 5 (left) and 7 (right), with hy-
drogen atoms and phenyl rings omitted for clarity. 
Table 4: Calculated spectroscopic data for 5 and 7. 
 B3LYPa,b PBEPBEa,b  
 δP δC δH δP δC δH νCOa,c /cm-1 
5 94.1 96.9 3.52 73.3 100.9 3.99 1912.8 
7 108.1 65.3 2.30 82.6 65.8 2.1 1915.9 
alanl2dz on Ru, 6-31G** on all other atoms. bdata for the P−CH 
fragment, calculated using the GIAO method, referenced against  
H3PO4 and Me4Si at the same level of theory. c B3LYP, frequency 
scaling factor of 0.961 applied.  
Mechanistic considerations.  The mechanism by which 
compounds 5 − 14 form from the respective phosphaalkenyls 
and Lipz’ is the subject of on-going experimental and compu-
tational studies; however, brief comment is warranted.  Intui-
tively, one might anticipate nucleophilic attack at the rutheni-
um center, given its predominant contribution to the LUMO 
and accessibility through the basal plane.  Indeed, complex 1 
was shown to readily add donors (CO, CNR) at this site,15 
albeit that an apparently strong trans influence imparted sig-
nificant lability.  Moreover, the reaction of 1 with the carbox-
ylate salts Na[O2CR] (R = H, Fc) was shown to afford 
[Ru{P=CHtBu}(O2CH)(CO)(PPh3)2] via formal nucleophilic 
displacement of chloride,15 presumably via an associative 
mechanism.  It is also reasonable to consider that in the reac-
tion of 1 or 2 with electrophilic species such as RHgCl, MeI or 
AuCl(L),15,19a,b,e,20 the ensuing 1,2 addition across the Ru−P 
bond involves installation of a nucleophilic fragment (X−) at 
the vacant metal site, though whether this is concomitant with 
addition of the electrophilic fragment to phosphorus, or facili-
tated by it, has not been established.  
However, one cannot arbitrarily dismiss the possibility of 
initial nucleophilic attack at the phosphorus center.  While 
nucleophilicity at this site is characteristic of 1-electron phos-
phaalkenyls and has been well established for both 115 and 2,20 
NBO analysis (vide supra) has provided evidence of apprecia-
ble δ+ character.  Moreover, as noted, the pi*(P=C) orbital is a 
significant component of the LUMO+1 (LUMO+2 in 1), 
which lies moderately close in energy to the LUMO (∆E ~ 0.6 
eV), thus offering a viable competitive pathway.  Notwith-
standing, in the formation of 11 − 14, we have inferred the 
influence of sterics in directing the bulkier CF3 substituent (cf. 
H, Me) to orient away from the metal center; we have also 
noted this in the reaction of 2 with LipztBu.35  While not fully 
excluding the possibility of attack at phosphorus,36 this out-
come would necessarily follow from an associative addition to 
ruthenium, sterics likely precluding approach of the more en-
cumbered (α-CF3 or tBu) nitrogen center.  Thus, while we are 
yet to reach a definitive conclusion, weight of evidence would 
currently suggest initial addition to the ruthenium center, pre-
sumably followed by elimination of LiCl.  However, the pro-
cess by which the putative pyrazolate complexes 
[Ru{P=CH(R)}(pz’)(CO)(PPh3)2] subsequently convert to 
[Ru{η1−N:η2−P,C-P(pz’)=CH(SiMe3)}(CO)(PPh3)2] with 
concomitant reduction of the metal remains unclear.   
 
CONCLUDING REMARKS 
We have described the synthesis of several ruthenaphos-
phaalkenyl complexes by the hydroruthenation of the silyl-
phosphaalkynes RMe2SiC≡P (R = Me, Ph, p-Tol), and provid-
ed the first structural (X-ray and DFT) characterization of 
these intriguing compounds.  The complexes are thus con-
firmed to adopt square-pyramidal geometry about ruthenium 
and comprise a formal 1-electron phosphaalkenyl ligand, as 
was previously inferred for [Ru{P=CH(tBu)}Cl(CO)(PPh3)2] 
on the basis of reactivity studies.  While that latter remains 
elusive to crystallographic study, DFT has provided adequate 
evidence to confirm a comparable geometry to its silyl coun-
terparts.   
All of the complexes are found to react with lithium pyrazo-
lates, seemingly resulting in reduction of both the metal 
(Ru(II) → Ru(0)) and phosphaalkenyl moiety.  The resulting 
complexes exhibit a metallacyclic core (Ru−P−C) that might 
feasibly be described as a ruthenaphosphirane, the Ru−P bond 
of which is additionally bridged by the pyrazolyl group.  
However, spectroscopic and structural data are inconclusive, 
being equally consistent with the η2-coordination of a phos-
phaalkene, tethered by the pyrazolyl moiety, with a dominant 
bonding contribution from dpi→pi*(P=C) retro-donation.  Indeed, 
on balance, we currently favor this description, based on the 
Dewar-Chatt-Duncanson model.  Regardless of the correct 
formalism, the process by which these novel complexes are 
obtained is equally intriguing and remains to be firmly estab-
lished.  While it is not currently possible to fully discount the 
direct nucleophilic attack at phosphorus – which would imply 
true ambiphilic character for the phosphaalkenyl ligand, for 
which some support is found – evidence would seem to favor 
initial addition of the pyrazolate to ruthenium.  However, the 
full mechanistic features of this reaction remain to be estab-
lished, and are the subject of on-going investigations.     
     
EXPERIMENTAL SECTION 
General Methods.  All maniplations were performed under strict 
anaerobic conditions using standard Schlenk line and glovebox 
(MBraun) techniques, working under an atmosphere of dry argon or 
dinitrogen respectively.  Solvents were distilled from appropriate 
drying agents and stored over either molecular sieves (4 Å, for DCM 
and THF) or potassium mirrors.  General reagents were obtained 
from Sigma-Aldrich or Fisher and purified by appropriate methods 
before use, precious metal salts were obtained from STREM.  
[RuHCl(CO)(PPh3)3],




13,15 were prepared by 
literature methods.  Unless otherwise stated NMR spectra were 
recorded at 303 K, on Varian VNMRS 400 (1H 399.50 MHz, 13C 100.46 
MHz, 19F 375.87, 31P 161.71 MHz, 29Si 79.37 MHz); VNMRS 500 (1H 
499.91 MHz, 13C 125.72 MHz) or 600 (1H 599.69 MHz, 13C 150.81 
MHz, 31P 242.83 MHz) spectrometers were used in selected instanc-
es.  All spectra are referenced to external Me4Si, 85 % H3PO4 and 
CFCl3 as appropriate.  Carbon-13 spectra were assigned by recourse 
to the 2D (HSQC, HMBC) spectra; phosphaalkenic proton and silicon 
shifts were determined indirectly by 1H-31P and 1H-29Si correlation 
(HMBC).  Mass spectrometry was performed by Dr A. Abdul-Sada of 
 the departmental service. Elemental analyses were obtained by Mr S. 
Boyer of the London Metropolitan University Elemental Analysis 
Service.   
X-ray diffraction studies. Single crystal X-ray diffraction data were 
recorded on an Agilent Xcalibur  Eos Gemini Ultra diffractometer 
with CCD plate detector using Mo-Kα (λ = 0.71073) or Cu-Kα (λ = 
1.54184) radiation.  Structure solution and refinement were per-
formed using SHELXS40 and SHELXL40 respectively, running under 
WinGX41 or Olex2.42 
DFT calculations.  Calculations were performed using Gaussian 
09W, Revision C.01,43 running on an Intel Core i5-2500 (quad, 3.3 
GHz), equipped with 4 GB RAM; results were visualized using 
GaussView 5.0.  Geometries were optimized with the hybrid density 
functional B3LYP, using the RECP basis set Lanl2dz for Ru and 6-
31G** for all other atoms.  Minima were characterized by frequency 
calculations, and calculated frequencies adjusted by standard scaling 
factors.  NMR shielding tensors were calculated at the same level of 
theory with both the B3LYP and PBEPBE functionals using the GIAO 
method, and compared against those similarly calculated for the 
respective reference standards to derive chemical shifts.   
(p-Tol)Me2SiCH2Cl.  To a cooled (−10 °C), stirred ethereal solution 
(30 cm3) of ClMe2SiCH2Cl (10 cm
3, 0.076 mol) was added a thf solu-
tion of p-TolMgBr (57 cm3, 1.33M, 0.065 mol).  After 45 min. the 
mixture was brought to reflux for 18 h., then allowed to cool to am-
bient temperature with continued stirring.  The solvents were re-
moved by distillation at ambient pressure, then the residue distilled 
under reduced pressure (2.3 mbar, 55 °C) to afford (p-Tol)Me2SiCH2Cl 
as a colorless liquid (6.6 g, 43 %) which was identified on the basis of 
literature data.44  1H NMR (CDCl3): δ : 0.41 (s, 6H, Si(CH3)2), 2.37 (s, 
3H, CH3-Ar), 2.94 (s, 2H, CH2Cl),  7.21 (d, J = 7.71Hz, 2H, Ar-H), 7.45 
(d, J = 7.71, 2H, Ar-H).13C NMR (CDCl3): δ 4.3 (s, 
1JSiC = 54.1 Hz, 
Si(CH3)2), 21.6 (s Ar-CH3), 30.7 (s, CH2Cl), 128.98 (s, Ar-H), 133.9 (s, 
Ar-H). 29Si NMR (CDCl3): δ −4.1.   
(p-Tol)Me2SiCH2PCl2.  Following from literature methods for relat-
ed compounds,23 TolMe2SiCH2Cl (6.6 g, 0.033 mol) in ether (15 cm
3) 
was added, drop-wise, to a stirring suspension of activated Mg (2.0 g, 
0.08 mol) in ether (20 cm3), at a rate to maintain reflux.  Stirring was 
continued while the reaction cooled to ambient temperature, and 
then for a further 2 h.; the mixture was then filtered directly into an 
ethereal solution (20 cm3) of PCl3 (4.5 cm
3, 0.05 mol) held at −78 °C.  
The mixture was then stirred for 30 minutes at this temperature, 
before being allowed to warm to ambient temperature over the 
course of 18 h.  The solution was filtered and the residues washed 
with Et2O (3 x 15 cm
3); the combined filtrate was stripped of Et2O by 
distillation at ambient temperature to afford a colorless liquid (5.92 
g, 67 %).  1H NMR (CDCl3): δ : 0.48 (s, 6H SiMe2),  2.24 (d, 
2JPH = 15.2 
Hz, CH2), 2.37 (s, 3H, Me), 7.22 (d,
3JC-H = 7.4 Hz, Ar-H), 7.44 (d, 
3JC-H = 
7.4 Hz, Ar-H). 13C{1H} NMR (CDCl3): δ : -1.33 (s, SiMe2), 21.6 (s, CH3), 
35.2 (d, 1JC-P = 61 Hz, CH2), 129.1 (s, Ar-H), 133.1 (d, 
3JC-P = 4 Hz, Si-C), 
133.7 (Ar-H), 140.0 (s, C-Me).   29Si NMR (CDCl3): -6.7.  
31P NMR 
(CDCl3): 203.3.   
(p-Tol)Me2SiC≡P.  As previously described for RMe2SiC≡P (R = Me, 
Ph),20,38 TolMe2SiCH2PCl2 (0.595 g, 2.4 mmol) as solution in toluene 
was added to a toluene suspension of AgOTf (1.26 g, 4.9 mmol); after 
stirring 10 min., DABCO (0.550 g, 4.9 mmol) was added as solution 
toluene.  After stirring for 1 h. the mixture was filtered and then 
calibrated for concentration by integration of its 31P{1H}-NMR reso-
nance (δP 103.3) against that of fully relaxed (d1 = 150 s) PPh3.  Sam-
ples are stored below 5 °C (< 1 week) and recalibrated before use. 
[Ru{P=CH(SiMe2R)}Cl(CO)(PPh3)2] (R = Me 2, Ph 3, p-Tol 4).  In a 
typical reaction, to a stirring suspension of [RuHCl(CO)(PPh3)2] (1.5 g, 
1.53 mmol) in CH2Cl2 (15 cm
3) was added an excess (1.3 equiv.) of 
RMe2SiC≡P as solution in toluene (ca 25 cm
3).   After stirring for 1 h. 
the solvent was removed under reduced pressure to afford an or-
ange/brown residue, which was washed vigorously with n-hexane (3 
x 10 cm3).  The solvent was then removed by filtration, to afford a 
yellow to orange solid, which was dried in vacuo. Data for 2: Yield: 95 
%. 1H-NMR (C6D6, 499.9 MHz): δH 7.92 – 7.85 (m, 12 H, PAr3), 7.39 (s, 
1H, P=CH), 7.08 − 6.98 (m, 18 H, PAr3), 0.18 (s, JSiH 6.5 Hz, 9 H).  
13C{1H}-NMR (C6D6) δC 203.0 (m, C≡O), 168.0 (br., CH, P=CH), 134.1, 
132.2, 127.6 (m, CH, PAr3 x 3), 0.9 (d, JCP 6.4 Hz, Si(CH3)3). 
31P{1H}-
NMR (C6D6) δP 34.6 (d, JPP 8 Hz), 548.5 (t, JPP 8 Hz). 29Si{1H}-NMR (C6D6) 
δSi −9.4. νCO = 1920 cm-1.  Anal. Found: C, 60.91; H, 4.82; Calcd for 
C41H40ClOP3RuSi: C, 61.07; H, 5.00.  X-ray quality crystals were ob-
tained by storage of a saturated ether solution at 4 °C for several 
days.  Crystal data for 2: C41H40ClOP3RuSi.C4H10O, Mw = 954.49, mon-
oclinic, P21/c (no. 14), a = 9.7961(5), b = 34.2580(17), c = 14.8457(7) 
Å, β = 95.201(5) °, V = 4961.6(4) Å3, Z = 4, Dc = 1.278 Mg m-3, µ(Cu-
Kα) = 4.491 mm-1, T = 173(2) K, 9180 independent reflections, full-
matrix F2 refinement R1 = 0.0876, wR2 = 0.2864 on 6502 independent 
absorption corrected reflections [I > 2σ(I); 2θmax = 141.8 °], 473 pa-
rameters, CCDC 1036624 
Data for 3:  1H-NMR (CD2Cl2): δH 7.66 – 7.56 (m, 12 H, Ar=), 7.50 – 
7.41 (m, 8 H, Ar), 7.40 (s, 1H, P=CH), 7.39 − 7.29 (m, 12 H, Ar), 0.26 (s, 
JSiH 6.3 Hz, 6 H, SiMe2).  
13C{1H}-NMR (CD2Cl2, 150.81 MHz, 298  K) δC 
201.9 (t, JPC 15 Hz, C≡O), 163.7 (d., JPC = 77 Hz, CH, P=CH), 134.3 (t, JPC 
5.5 Hz, CH, PAr), 133.5 (s, CH, Ph), 132.1 (t, JPC 23.2 Hz, C, PAr),  130.3 
(s, CH, Ph), 128.5 (s, C, Ph), 128.2 (t, JPC 5.2 Hz, CH, PAr), 127.5 (s, CH, 
Ph), -1.3 (d, JCP 7.7 Hz, Si(CH3)2). 
31P{1H}-NMR (CD2Cl2) δP 553.8 (t, JPP 8 
Hz), 33.7 (d, JPP 8 Hz). 
29Si{1H}-NMR (C6D6,) δSi −14.3. νCO = 1938 cm-1.  
Anal. Found: C, 63.53; H, 4.75; Calcd for C44H42ClOP3RuSi: C, 63.63; H, 
4.88.  X-ray quality crystals were obtained by slow evaporation of a 
saturated CH2Cl2/hexane solution at ambient temperature.  Crystal 
data for 3: C44H42ClOP3RuSi, Mw = 868.37, monoclinic, P21/c (no. 14), 
a = 19.6355(5), b = 11.9196(2), c = 19.5933(5) Å, β = 116.565(3) °, V = 
4101.6(2) Å3, Z = 4, Dc = 1.406 Mg m
-3, µ(Cu-Kα) = 5.346 mm-1, T = 
173(2) K, 7897 independent reflections, full-matrix F2 refinement R1 = 
0.0267, wR2 = 0.0714 on 7237 independent absorption corrected 
reflections [I > 2σ(I); 2θmax = 143.6 º], 479 parameters, CCDC 1036625   
Data for 4: Yield: 59 %.  1H-NMR (CD2Cl2, 499.9 MHz) δH 0.20 (s, 
6H, Si(CH3)2), 2.31 (s, 3H, CH3),  6.9-7.46, 7,55-7.61 (2 x m, 30H PAr3,  
4H C6H4, 1H P=C). 
13C{1H}-NMR (CD2Cl2) δC 1.4 (s, Si(CH3)2 ), 21.7 (s, 
Ar-CH3), 127.3 (dd, J = 7 Hz, 9 Hz,  P-Ar), 128.0, (t, J = 5 Hz), 128.8 (t, 
J= 5 Hz), 130.1 (ipso-CH) 129.8 (P-Ar), 129.5 (P-Ar),  130.9 (P-Ar),  
132.8 (t, J = 23 Hz, PAr),134.3 (o-CH),135.0 (m, PAr), 135.7 (m, P-Ar), 
136.5 (t, J = 23 Hz, P-Ar) , 138.28 (para-CH),  165.2 (br., C=P), 202.5 
(br, CO).  31P{1H}-NMR (CD2Cl2) δP 33.7 (d, JPP 8 Hz, PPh3), 552.6 (t, JPP 
8 Hz, P=C). 29Si{1H}-NMR (CD2Cl2): δSi  -14.4. νCO = 1936 cm
-1. 
 Anal. 
Found: C, 64.02; H, 5.14; Calcd for C47H44ClOP3RuSi: C, 63.98; H, 5.03.  
X-ray quality crystals were obtained by slow evaporation of a satu-
rated CH2Cl2 solution at ambient temperature.  Crystal data for 4: 
C47H44ClOP3RuSi, Mw = 882.34, monoclinic, P21/c (no. 14), a = 
19.6947(6), b = 12.0013(2), c = 19.7876(5) Å, β = 116.762(4),°, V = 
4176.0(2) Å3, Z = 4, Dc = 1.403 Mg m
-3, µ(Cu-Kα) = 5.259 mm-1, T = 
173(2) K, 6511 independent reflections, full-matrix F2 refinement R1 = 
0.0384, wR2 = 0.1118 on 5898 independent absorption corrected 
reflections [I > 2σ(I); 2θmax = 123.6 °], 490 parameters, CCDC 
1036626. 
 [Ru{η1−N:η2−P,C-P(pz)=CH(tBu)}(CO)(PPh3)2] (5). At ambient 
temperature, to a solution of pzH (0.010 g, 0.150 mmol) in THF (5 
cm3) was added nBuLi (0.06 cm3, 2.5M, 0.150 mmol).  The mixture 
was stirred for ca 10 min. then transferred via cannula to a stirred 
solution of 1 (0.119 g, 0.150 mmol).  After stirring for 1 h. the solvent 
was removed under reduced pressure, then the product extracted 
into CH2Cl2 (5 cm
3), filtered and taken to dryness in vacuo.  Yield: 
0.078 g, 63 %.  1H NMR (CD2Cl2) δH: 7.36–7.10 (m, 30 H, P(C6H5)), 6.91 
(d, JHH = 2.26 Hz, 1 H, Pz-H
3), 5.58 (br, 1 H, Pz-H5), 5.54 (m, 1 H, Pz-
H4), 2.84 (m, 1 H, P–CH), 0.88 (s, 9 H, C(CH3)3).  
13C{1H} NMR (CD2Cl2) 
δC: 211.7 (m, C≡O), 140.9 (s, Pz-C
3), 135.9 (s, Pz-C5), 138.8–128.2 (m, 
P(C6H5)), 105.2 (s, Pz-C
4), 81.6 (ddd, JCP = 68.65, 36.36, 4.83 Hz), CH
t-
Bu), 37.7 (d, JCP = 14.83 Hz, C(CH3)3), 33.4 (m, C(CH3)3). 
31P{1H} NMR 
(CD2Cl2) δP: 44.2 (dd, JPP = 17.45, 8.10 Hz), 42.5 (dd, JPP = 47.14, 17.42 
 Hz), 38.8 (dd, JPP = 47.02, 8.17 Hz, P=C).  νCO/cm
−1 1906.  Anal Found: 
C, 62.34 %; H, 5.42 %; N, 3.58 %. Calcd for C45H43P3N2ORu.0.75CH2Cl2: 
C, 62.05 %; H, 5.07 %; N, 3.16 %.45 
[Ru{η1−N:η2−P,C-P(pz*)=CH(tBu)}(CO)(PPh3)2] (6). Prepared as for 
5, commencing with pz*H (0.155 g, 0.160 mmol), nBuLi (0.07 cm3, 2.5 
M, 0.160 mmol) and 1 (0.126 g, 0.160 mmol).  Yield: 0.090 g, 66 %. 1H 
NMR (CD2Cl2) δH: 7.39–7.13 (m, 30 H, P(C6H5)), 5.14 (s, 1 H, Pz*-H
4), 
2.90 (ddd, JHP = 5.70, 3.28, 2.38 Hz, (
1JCH = 137 Hz), 1 H, P–CH), 1.96 
(s, 3 H, Pz*-CH3-5), 0.91 (s, 9 H, C(CH3)3), 0.43 (s, 3 H, Pz*-CH3-3).  
13C{1H} NMR (CD2Cl2) δC: 211.8 (m, C≡O), 152.4 (s, Pz*-C
3), 145.6 (d, 
JCP = 1.63 Hz, Pz*-C
5), 134.7–134.2 (m, P(C6H5)), 129.5–128.0 (m, 
P(C6H5)), 105.6 (s, Pz*-C
4), 79.8 (ddd, JCP = 66.67, 36.99, 5.43 Hz, CH
t-
Bu), 37.7 (d, JCP = 13.72 Hz, C(CH3)3), 34.0 (dd, JCP = 9.47, 3.67 Hz, 
C(CH3)3), 12.1 (s, Pz*-CH3-3), 9.6 (d, JCP = 5.26 Hz, Pz*-CH3-5). 
31P{1H} 
NMR (CD2Cl2) δP: 45.5 (dd, JPP = 17.28, 8.64 Hz), 41.4 (dd, JPP = 50.36, 
16.98 Hz), 14.7 (dd, JPP = 50.44, 8.56 Hz, P=C).  νCO/cm
−1 1906.  MS 
[FAB]: m/z (%): 850 [M+], 751 [M − Pz*]+, 655 [M − Pz* − PC(H)tBu]+.  
Anal Found: C, 62.27 %; H, 5.41 %; N, 3.26 %. Calcd for 
C47H47N2OP3Ru: C, 66.43 %; H, 5.57 %; N, 3.30 %. 
[Ru{η1−N:η2−P,C-P(pz)=CH(SiMe3)}(CO)(PPh3)2] (7). Prepared as 
for 5 from pzH (0.010 g, 0.150 mmol), nBuLi (0.06 cm3, 0.150 mmol) 
and 2 (0.121 g, 0.150 mmol).  Yield: 0.090 g, 72 %.  31P{1H}-NMR 
(CD2Cl2, 161.7 MHz) δP 58.7 (d, JPP 47 Hz), 46.6 (d, JPP 18 Hz), 42.0 (dd, 
JPP 47, 18 Hz). 
1H-NMR (CD2Cl2): δH 7.38 – 7.30, 7.27 – 7.17, 7.12 − 
7.06 (3 x m, 30 H, PAr3) 6.89 (br. 1H, pz-H
3), 5.48 (br. 1H, pz-H5), 5.45 
(br. 1 H, pz-H4), 1.59 (br., 1 H, P-CH), 0.18 (s, 9 H, Si(CH3)3).  
13C{1H}-
NMR (CD2Cl2) δC 211.2 (m, C≡O), 141.3 (pz-C3), 135.7 (pz-C4), 138.2 
(m, ipso-PAr3), 134.3, 129.0, 128.3 (3 x CH, PAr3), 105.0 (pz-C
5), 47.6 
(ddd, JCP 79, 31, 4 Hz, P-CH(SiMe3)), 1.6 (dm, JCP 5 Hz, Si(CH3)3).  
29Si{1H}-NMR (CD2Cl2): δSi −1.38.  νCO = 1906 cm-1.  Anal. Found: C, 
62.95; H, 5.15; N, 3.30. Anal. Calcd. For C44H43P3N2OSiRu: C, 63.08; H, 
5.13; N, 3.34. 
[Ru{η1−N:η2−P,C-P(pz*)=CH(SiMe3)}(CO)(PPh3)2] (8). Prepared as 
for 6 from pz*H (0.013 g, 0.135 mmol), nBuLi (0.05 cm3, 0.125 mmol) 
and 2 (0.105 g, 0.120 mmol).  Yield: 0.080 g, 77 %.    13C{1H}-NMR 
(CD2Cl2, 100.5 MHZ) δC 210.4 (m, CO), 152.9 (pz*-C3), 145.7 (d, JCP 
1.4 Hz, pz*-C5), 138.7 (C, ipso-PAr3), 135.7, 129.5, 128.2 (3 x CH, 
PAr3), 105.5 (d, JCP 2.7 Hz, pz*-C
4), 44.9 (ddd, JCP 78, 32, 5 Hz, P-
CH(SiMe3)), 12.2 (s, pz*-CH3-3), 9.7 (s, pz*-CH3-5) 2.2 (dm, JCP 6 Hz, 
Si(CH3)3).  
31P{1H}-NMR (CD2Cl2) δP 46.6 (d, JPP 17 Hz), 39.3 (dd, JPP 50, 
17 Hz), 32.9 (d, JPP 47 Hz). 
1H-NMR (CD2Cl2): δH 7.58 – 7.53, 7.38 – 
7.23, 7.21 − 7.13 (3 x m, 30 H, PAr3), 5.12 (br., 1 H, pz-H
4), 1.62 (br., 1 
H, P-CH), −0.13 (s, 9 H, Si(CH3)3).  
29Si{1H}-NMR (CD2Cl2): δSi 1.28.  νCO 
= 1907 cm-1.  Anal. Found: C, 63.35; H, 5.44; N, 3.32. Anal. Calcd. For 
C46H47P3N2OSiRu: C, 63.52; H, 5.41; N, 3.22. 
[Ru{η1−N:η2−P,C-P(pz)=CH(SiMe2Ph)}(CO)(PPh3)2] (9). Prepared 
as for 5 from pzH (0.020 g, 0.299 mmol), nBuLi (0.12 cm3, 0.300 
mmol) and 3 (0.260 g, 0.299 mmol).  Yield: 0.137 g, 51%.  1H NMR 
(CD2Cl2) δH: 7.47–7.07 (m, 35 H, P(C6H5) + Ph), 5.46 (br, 1 H, Pz-H
4), 
7.52 (d, JHH = 2.08 Hz, 1 H, Pz-CH
5), 6.81 (d, JHH = 2.08 Hz, 1 H, Pz-CH
3), 
1.72 (m, (1JCH = 149 Hz), 1 H, CHSi), 0.13 (s, 3 H, Si(CH3)2), −0.08 (s, 3 
H, Si(CH3)2). 
13C{1H} NMR (CD2Cl2) δC: 211.1 (br, C≡O), 141.4 (s, Pz-C
3), 
135.9 (s, Pz-C5), 135.1–127.8 (m, P(C6H5)), 106.1 (br, Pz-C
4), 45.1 
(ddd, JCP = 3.58, 29.40, 79.52 Hz, CHSi), 0.3 (d, JCP = 4.33 Hz, Si(CH3)2), 
–1.6 (d, JCP = 10.42 Hz, Si(CH3)2).
 31P{1H} NMR (CD2Cl2) δP: 57.0 (d, JPP = 
47.05 Hz, P=C), 47.0 (d, JPP = 17.77 Hz), 41.7 (dd, JPP = 46.98, 17.63 
Hz). 29Si{1H} NMR (CD2Cl2) δSi: −6.6. νCO = 1913 cm
-1.  Anal Found: C, 
62.37%; H, 5.01%; N, 3.49%. Calcd for C49H45N2OP3SiRu.0.5CH2Cl2: C, 
63.08 %; H, 4.92 %; N, 2.97 %.45 
[Ru{η1−N:η2−P,C-P(pz*)=CH(SiMe2Ph)}(CO)(PPh3)2] (10). Pre-
pared as for 6 from pz*H (0.035 g, 0.368 mmol), nBuLi (0.15 cm3, 
0.375 mmol) and 3 (0.318 g, 0.367 mmol).  Yield: 0.124 g, 37 %.  1H 
NMR (CD2Cl2) δH: 7.50 (m, 5 H, Ar), 7.36–7.14 (m, 30 H, Ar) (PPh3 + 
Ph), 5.12 (s, 1 H, Pz*-H4), 1.98 (br, 3 H, Pz*-CH3-5), 1.77 (br, 1 H, (
1JCH 
= 128.49 Hz), CHSi), 0.43 (br, 3 H, Pz*-CH3-3), 0.17 (s, 3 H, Si(CH3)), 
−0.02 (s, 3 H, Si(CH3)). 
13C{1H} NMR (CD2Cl2) δC: 210.1 (m, C≡O), 153.1 
(s, Pz*-C3), 145.7 (d, JCP = 1.69 Hz, Pz*-C
5), 136.1–127.9 (m, P(C6H5)), 
106.7 (d, JCP = 2.74 Hz, Pz*-C
4), 41.8 (ddd, JCP = 78.19, 32.40, 4.35 Hz, 
CHSi), 12.1 (s, Pz*-CH3-3), 9.7 (d, JCP = 5.45 Hz, Pz*-CH3-5), 0.5 (d, JCP = 
8.78 Hz, Si(CH3)2), −0.4 (d, JCP = 7.61 Hz, Si(CH3)2). 
31P{1H} NMR 
(CD2Cl2) δP: 47.0 (d, JPP = 16.46 Hz, 38.9 (dd, JPP = 50.75, 16.67 Hz), 
32.3 (d, JPP = 50.21 Hz, P=C). 
29Si{1H} NMR (CD2Cl2) δSi: −4.9. νCO = 
1910 cm-1.  Anal Found: C, 65.87 %; H, 5.29 %; N, 3.09 %. Calcd for 
C51H49P3N2OSiRu: C, 66.01 %; H, 5.32 %; N, 3.02 %.  
[Ru{η1−N:η2−P,C-P(pz’)=CH(SiMe3)}(CO)(PPh3)2] (pz’ = pzH,CF3 11; 
pz
Me,CF3
 12).  Prepared in analogous fashion to 7 and 8, by lithiation 
of the respective pz’H, and subsequent addition to 1 equiv. 2 as solu-
tion in thf.  Data for 11: 1H NMR (CDCl3) δH: 7.39–7.16 (br. m, 24 H, 
C6H5), 7.07 (br. m, 6 H, C6H5), 5.59 (s, 1 H, Pz
CF3-H4), 5.28 (s, 1 H, PzCF3-
H3) 1.78 (br. s, 1 H, CHSi), −0.17 (s, 9 H, Si(CH3)3). 
13C{1H} (CDCl3) δC: 
190.0 (C≡O), 137.3 (m, C, PC6H5 ipso); 135.9 (s, Pz
CF3-C5), 133.6 (m, 
CH, PC6H5) 128.6 (obscured, q, JCF 248 Hz, CF3), 127.9 (m CH, PC6H5), 
0.98 (s, SiCH3) remaining resonances not resolved. 
31P{1H} NMR 
(CDCl3) δP: 76.6 (dq, JPP = 43.68 Hz, 
4JPF = 18.40 Hz, P=C), 47.7 (d, JPP = 
18.13 Hz), 41.5 (dd, JPP = 43.85, 17.99 Hz). 
29Si{1H} NMR (CDCl3) δSi: 
−1.1. 19F NMR (CDCl3) δF: −60.1 (d, 
4JFP = 18.07 Hz).  νCO = 1912 cm
-1.  
Anal Found: C, 59.60%; H, 4.52%; N, 3.15%. Calcd for 
C45H42P3F3N2OSiRu: C, 59.67%; H, 4.64%; N, 3.09%.  Data for 12:  
1H 
NMR (CDCl3) δH: 7.45–7.41 (br.m, 6 H,C6H5), 7.27–7.20 (br. m, 18 H, 
C6H5), 7.16–7.12 (br. m, 6 H, C6H5), 5.52 (s, 1 H, Pz
Me,CF3-H4), 1.76 (s 
(1JCH = 129.3 Hz), 1 H, CHSi), 0.55 (s, 3 H, CH3), −0.13 (s, 9 H, Si(CH3)3). 
13C{1H} NMR (CDCl3) δC: 209.2 (br. m, C≡O), 152.5 (br. m, Pz
Me,CF3-C3), 
137.8 (dd, J = 30.98, 1.60 Hz, PzMe,CF3-C5), 134.3–133.6 (m, C6H5), 
129.2–128.6 (m, C6H5), 128.0–127.7 (m, C6H5), 119.2 (q, JCF 268 Hz, 
CF3), 105.6 (br. m , Pz
Me,CF3-C4), 45.2 (ddd, JCP = 80.06, 31.84, 4.63 Hz, 
SiCH), 11.8 (s, PzMe,CF3-CH3-3), 1.7 (dd, JCP = 5.83, 1.40 Hz, Si(CH3)3). 
31P{1H} NMR (CDCl3) δP: 64.6 (dq, JPP = 46.79 Hz, 
4JPF = 20.19 Hz, P=C), 
46.9 (dd, JPP = 16.85, 1.09 Hz), 38.4 (ddq, JPP = 46.79, 16.86 Hz, 
6JPF = 
1.79 Hz). 29Si{1H} NMR (CDCl3) δSi: 2.2. 
19F NMR (CDCl3) δF: −60.0 (d, 
4JFP = 20.13 Hz).  νCO = 1909 cm
-1. Anal. Found: C, 59.90; H, 4.72; N, 
2.98. Anal. Calcd. For C46H44F3P3N2OSiRu: C, 60.07; H, 4.82; N, 3.04. 
Ru{η1−N:η2−P,C-P(pz’)=CH(SiMe2Ph)}(CO)(PPh3)2] (pz’ = pzH,CF3 
13; pz
Me,CF3
 14).  Prepared in analogous fashion to 7 and 8, by lithia-
tion of the respective pz’H, and subsequent addition 1 equiv. 2 as 
solution in thf.  Compound 14 forms alongside decomposition prod-
ucts, limited purification being achieved by extraction into hexane.34 
This compound is characterized spectroscopically ‘in situ’.  Data for 
13: 1H NMR (CDCl3) δH: 7.61 (br.m, 2 H, Si(C6H5)), 7.41–7.18 (br. m, 27 
H, C6H5), 7.08 (br.m, 6 H, C6H5), 5.61 (s, 1 H, Pz
CF3-H4), 5.36 (s, 1 H, 
PzCF3-H3), 1.97 (br.m, 1 H, CHSi), 0.18 (s, 3 H, Si(CH3)), −0.03 (s, 3 H, 
Si(CH3)). 
13C{1H} NMR (CDCl3) δC: 198.1 (br.m, C≡O), 142.3 (br.m, 
PzCF3-C3), 135.0–133.6 (m, C6H5), 129.9–127.3 (m, C6H5), 121.4 (q, JCF 
267 Hz, CF3), 103.3 (br.m, Pz
CF3-C4), 46.7 (m (br), SiCH), 0.15 (d (3JCP = 
5.24 Hz), SiCH3) remaining resonances are not resolved. 
31P{1H} NMR 
(CDCl3) δP: 74.9 (dq, 
2JPP = 44.45 Hz, 
4JPF = 17.60 Hz, P=CH), 48.0 (d, 
2JPP = 17.68 Hz), 41.3 (dd, 
2JPP = 44.45, 17.68 Hz). 
29Si{1H} NMR (CDCl3) 
δSi: −5.3. 
19F NMR (CDCl3) δF: −60.1 (d, 
4JFP = 19.48 Hz).  νCO = 1909 cm
-
1. High-res ESI+MS: m/z 968.1426 [M]+ (Err=2.07 ppm).  Anal. Found: 
C, 61.86; H, 4.49; N, 3.00. Anal. Calcd. For C50H44F3P3N2OSiRu: C, 
62.05; H, 4.58; N, 2.89.  Data for 14: 1H NMR (CDCl3) δH: 7.42 (br. m, 
12 H, C6H5), 7.23 (br. m, 14 H, C6H5), 7.15 (br. m, 9 H, C6H5) (PPh3 + 
Ph), 5.53 (s, 1 H, PzMe,CF3-H4), 1.97 (br. s,  1 H, 1JCH = 134.52 Hz, CHSi), 
0.56 (s, 3 H, CH3), 0.19 (s, 3 H, Si(CH3)), 0.01 (s, 3 H, Si(CH3)). 
13C{1H} 
NMR (CDCl3) δC: 209.0 (br. m, C≡O), 152.6 (br. m, Pz
Me,CF3-C3), 143.2 
(br. m, ipso-C6H5), 134.3–133.6 (m, C6H5), 129.2–128.6 (m, C6H5), 
128.0–127.5 (m, C6H5), 137.6 (dd, J = 31.06, 1.36 Hz, Pz
Me,CF3-C5), 
119.4 (q, JCF 270 Hz, CF3), 105.7 (br. m, 
1JCH = 129.77 Hz, Pz
Me,CF3-C4), 
41.8 (ddd, JCP = 80.61, 31.43, 4.93 Hz, SiCH), 11.9 (s, Pz
Me,CF3-CH3-3), 
0.16 (d, 3JCP = 8.53 Hz, SiCH3), −1.2 (d, 
3JCP = 7.66 Hz, SiCH3). 
31P{1H} 
NMR (CDCl3) δP: 62.7 (dq, JPP = 47.06 Hz, 
4JPF = 19.69 Hz, P=CH), 47.2 
(d, 2JPP = 16.25 Hz), 38.3 (dd, JPP = 47.03, 16.48 Hz). 
29Si{1H} NMR 
 (CDCl3) δSi: −6.0. 
19F NMR (CDCl3) δF: −59.8 (d, 
4JFP = 19.48 Hz). νCO = 
1915 cm-1.  High-res ESI+MS: m/z 982.1582 [M]+ (Err=4.57 ppm). 
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